Navigation Links
BioMS Medical Announces 2008 Year End Results
Date:3/17/2009

42,492 --------------------- 100,504 51,410 --------------------- --------------------- BioMS Medical Corp. (A Development Stage Corporation) Consolidated Statements of Operations and Comprehensive Loss ------------------------------------------------------------------------- (expressed in thousands of Canadian dollars and shares, except per share amounts) Cumulative from inception to Years December 31, ended December 31, ------------ ------------------- 2008 2008 2007 $ $ $ Research and development Revenue earned from collaboration partner 52,561 52,561 - Research and development expenses (152,085) (46,502) (38,907) ------------ ------------------- (99,524) 6,059 (38,907) General and administrative expenses (42,605) (13,790) (7,490) Amortization of licensing costs (11,755) (1,472) (1,472) Amortization of property and equipment (517) (125) (134) ------------ ------------------- Loss from operations (154,401) (9,328) (48,003) Other income (expense) Investment income 8,779 2,436 1,644 Foreign exchange gain (loss)
'/>"/>
SOURCE BioMS Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. BioMS Medical warrant extension
2. BioMS Medical to present at BIO CEO and Investor Conference
3. BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis
4. BioMS Medical recognized at Scrip Awards 2008
5. BioMS Medical Announces Third Quarter 2008 Results
6. BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference
7. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
9. BioMS Medical announces receipt of milestone payment from Eli Lilly and Company
10. BioMS Medical to present at Sachs Associates Biotech in Europe Forum
11. BioMS Medical to present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... The human skin is the largest organ, yet many do ... Similar to the liver, or heart, the skin must be ... Recent reports from the mankatofreepress.com explained how caring for the ... other life supporting organs. The article suggests several types of ... the appearance of skin, and fight off acne causing factors. ...
(Date:6/18/2013)... JERUSALEM , June 18, 2013 ... study using the company,s  proprietary AMCA Guided Bone Regeneration (GBR) ... dental implants. A common problem encountered when patients ... lack of sufficient bone volume to house the implant. Consequently ... a bone substitute until the natural bone regenerates. The bone ...
(Date:6/18/2013)... LONDON , June 18, 2013 /PRNewswire/ ... leading international investment research firm, announces the ... (BIO.PA), a French biopharmaceutical company developing and ... supportive care indications.      (Logo: ... a comprehensive report examining the investment merits ...
(Date:6/18/2013)... Israel , June 18, 2013 ... Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and finished ... that the company has been granted a United ... the US and Europe for the ... number 8,410,176 B2 is titled Intermediate Compounds and Processes ...
Breaking Biology Technology:Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2
... VALLEY COTTAGE, N.Y., March 11 XTL Biopharmaceuticals Ltd. (Nasdaq: ... Extraordinary General Meetings ("EGMs") were postponed for one week in ... of a quorum. The postponed EGMs will take place at ... 76100 at 3:00 p.m. and 5:30 p.m. Israel time on ...
... (NYSE Alternext US: DDD) today reported financial results for ... The Company will host a live conference call ... Time)."Last year was an important period for SCOLR Pharma," ... "Utilizing our unique CDT(R) platforms, we made significant progress ...
... LANSING, Mich., March 11 Neogen Corporation (Nasdaq: ... Neogen Corporation 3rd Quarter Results WebcastWhen: ... http://www.videonewswire.com/event.asp?id=56632 How: Live over the ... at the address above. Contact: Terry ...
Cached Biology Technology:SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 2SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 3SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 4SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 5SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 6SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 7SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 8
(Date:6/18/2013)... DNA and this modification can occur in millions ... scientists believed that this epigenetic phenomenon actively reduced ... of researchers from the University of Geneva (UNIGE), ... the Faculty of Medicine, reveals that this is ... may play both a passive and active role ...
(Date:6/17/2013)... have identified a new virus in patients with severe ... determine whether the virus is responsible for the symptoms ... total of 28 out of 644 patients with severe ... but not in any of the 122 patients with ... the brain and central nervous system are often fatal ...
(Date:6/17/2013)... understand the concept of improving original foundations with more ... the University of Pittsburgh,s Kenneth P. Dietrich School of ... that could make drug delivery, gas storage, and gas ... findings were reported in the latest issue of the ... JACS ). , The recent work builds upon Pitt ...
Breaking Biology News(10 mins):The secret of DNA methylation 2New virus isolated from patients with severe brain infections 2New virus isolated from patients with severe brain infections 3'Chemical architects' build materials with potential applications in drug delivery and gas storage 2
... A new University of Central Florida study will examine how ... the Florida Panhandle and Alabama and Mississippi coasts. The ... Civil Engineering, is a response to scientific studies that show ... Hagen,s research also could potentially be linked with models of ...
... free of charge so that customers can neutralise the heart ... suggest in a new study published this week. Statins ... A wealth of trial data has proven them to be ... In a paper published in the Sunday 15 August issue ...
... Mount Sinai School of Medicine, New York, has been ... receive a 2010 ICAAC Young Investigator Award. Sponsored ... an early career scientist for research excellence in microbiology ... postdoctoral training in Molecular Biology at Harvard University in ...
Cached Biology News:Study to examine rising sea level's impact on estuaries, coastal communities 2Free statins with fast food could neutralize heart risk, scientists say 2
... frozen Sf9 Insect Cells are derived from the ... for optimal growth, use in transfections, plaque assays, ... frozen in a protocol that optimizes recovery of ... growth in serum-free BacVector Insect Cell Medium and ...
... software package that provides crystallographers with ... buffer creation, set-up of experimental conditions ... The software helps crystallographers through the ... crystallography: Design of ...
... premium quality recombinant form of Thermus aquaticus ... for a wide range of PCR applications. ... performance, each preparation is extensively tested in ... DNA Polymerase possesses an integral 5′→3′ exonuclease ...
... direct antibiotic-based selection system for recombinant identification. ... eliminating the need for costly color screening. ... to 100% accuracy in recombinant selection. pLivSelect ... colony picking. This cloning kit can be ...
Biology Products: